Imaging in Neovascular Age-Related Macular Degeneration

REFERENCES

• Macular Photocoagulations Study Group. Argon laser photocoagulation for senile macular degeneration. Arch Ophthalmol. 1982;100:912–23.
   PubMedGoogle Scholar
• Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol. 1986;104:694–701.
   PubMed Web of Science ®Google Scholar
• Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials− TAP Report 1. Arch Ophthalmol. 1999;117:1329–45.
   PubMed Web of Science ®Google Scholar
• VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. TAP and VIP Report no. 1. Am J Ophthalmol. 2001;31:540–560.
   Google Scholar
• Zayit-Soudry S, Moroz I, Lowenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol. 2007;52:227–243.
   PubMed Web of Science ®Google Scholar
• Gass JDM. Stereoscopic Atlas of Macular Disease: Diagnosis and Management, 4th ed. St. Louis: Mosby, 1997,24–6.
   Google Scholar
• Bressler NM, Bressler SB, Fine SL. Neovascular (exudative) age-related macular degeneration. In: Ryan SJ, ed., Retina, 3rd ed. St. Louis: Mosby, 2001,1100–35.
   Google Scholar
• Roquet W, Roudot-Thoraval F, Coscas G, et al. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. Br J Ophthalmol. 2004;88:638–42.
   PubMed Web of Science ®Google Scholar
• Berkow JW, Flower RW, et al. Fluorescein and Indocyanine Green Angiography Technique and Interpretation, 2nd ed. San Francisco, CA: American Academy of Ophthalmology, 1997.
   Google Scholar
• Kwiterovich KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions after fluorescein angiography: Results of a prospective study. Ophthalmology. 1991;98:1139–1142.
   PubMed Web of Science ®Google Scholar
• Brown DM and Regillo CD. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 2007;144:627–637.
   PubMed Web of Science ®Google Scholar
• Hubschman JP, Reddy S, Schwartz SD. Age related macular degeneration: Experimental and emerging treatments. Clinical Ophthalmology. 2009;3:167–174.
   PubMedGoogle Scholar
• Kim SC, Lee SC, Seong YS, et al. Choroidal neovascularization characteristics and its size in optical coherence tomography. Yonsei Med J. 2003;44:821–827.
   PubMedGoogle Scholar
• Sandhu SS, Talks SJ. Correlation of optical coherence tomography, with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosis choroidal neovascular membranes. Br J Ophthalmol. 2005;89:967–970.
   PubMed Web of Science ®Google Scholar
• Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol. 2007;143:566–583.
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–434.
   PubMed Web of Science ®Google Scholar
• Zweifel SA, Engelbert M, Laud K, et al. Outer retinal tubulation: A novel optical coherence tomography finding. Arch Ophthalmol. 2009;127(12):1596–1602.
   PubMedGoogle Scholar
• Domalpally A, Danis RP, Zhang B, et al. Quality issues in interpretation of optical coherence tomograms in macular diseases. Retina. 2009;29:775–81.
   PubMed Web of Science ®Google Scholar
• Sandhu SS and Talks SJ. Correlation of optical coherence tomography with or without additional colour fundus photography, with stereo fundus fluorescein angiography in diagnosing choroidal neovascular membranes. Br J Ophthalmol. 2005;89:1184–1187.
   PubMedGoogle Scholar
• Eter N, Spaide RF. Comparison of fluorescein angiography and optical coherence tomography for patients with choroidal neovascularization after photodynamic therapy. Retina. 2005;25:691–696.
   PubMedGoogle Scholar
• Giani A, Cigada M, Choudhry N, et al. Reproducibility of retinal thickness measurements on normal and pathologic eyes by different optical coherence tomography instruments. Am J Ophthalmol. 2010;150(6):815–824.
   PubMedGoogle Scholar
• Hassenstein A, Meyer CH. Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography: A review. Clin Exper Ophthalmol. 2009;37:130–143.
   PubMedGoogle Scholar
• Yannuzzi LA, Ober MD, Slackter JS, et al. Ophthalmic fundus imaging: Today and beyond. Am J Ophthalmol. 2004;137:511–524.
   PubMed Web of Science ®Google Scholar
• Flower RW, Csaky KG, Murphy RP. Disparity between fundus camera and scanning laser ophthalmoscopic indocyanine green imaging of retinal pigment epithelial detachments. Retina. 1998;18:260.
   PubMedGoogle Scholar
• Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal vasculopathy (IPCV). Retina. 1990;10(1):1–8.
   PubMedGoogle Scholar
• Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeabilitiy. Am J Ophthalmol. 2006;142(4):601–7.
   PubMedGoogle Scholar
• Hope-Ross, M, Yannuzzi LA, Gragoudas ES, et al. Adverse reactions due to indocyanine green. Ophthalmology. 1994;101:529–33.
   PubMed Web of Science ®Google Scholar
• Bonte CA, Ceuppens J, Leys AM. Hypotensive shock as a complication of indocyanine green injection. Retina. 1998;18:476–7.
   PubMedGoogle Scholar
• Olsen TW, Lim JI, Capone A Jr, et al. Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol. 1996;114:97.
   PubMedGoogle Scholar
• Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: Indications and Interpretation. Ophthalmology. 2003;110:15–24.
   PubMed Web of Science ®Google Scholar
• Gaillard ER, Atherton SJ, Eldred G, et al. Photophysical studies on human retinal lipofuscin. Photochem Photobiol. 1995;61:448–453.
   PubMed Web of Science ®Google Scholar
• Schmitz-Valckenberg S, Holz FG, Bird AC, and Spaide RF. Fundus autofluorescence imaging. Retina. 2008;28:385–409.
   PubMed Web of Science ®Google Scholar
• Schmitz-Valckenberg S, Fleckenstein M, School HPN, and Holz FG. Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmology. 2009;54:96–117.
   PubMed Web of Science ®Google Scholar
• Dorey CK, Wu G, Ebenstein D, et al. Cell loss in the aging retina. Relationship to lipofuscin accumulations and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691–1699.
   PubMed Web of Science ®Google Scholar
• Holz FG, Bellman C, Staudt S, et al. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:1051–1056.
   PubMed Web of Science ®Google Scholar